RECOMBINATE 1000 IU

Quốc gia: Israel

Ngôn ngữ: Tiếng Anh

Nguồn: Ministry of Health

Thành phần hoạt chất:

COAGULATION FACTOR VIII RECOMBINANT 1000 IU/VIAL

Sẵn có từ:

TEVA MEDICAL MARKETING LTD.

Mã ATC:

B02BD02

Dạng dược phẩm:

POWDER FOR SOLUTION FOR INJECTION

Tuyến hành chính:

I.V

Sản xuất bởi:

BAXTER S.A., BELGIUM

Nhóm trị liệu:

COAGULATION FACTOR VIII

Chỉ dẫn điều trị:

The use of Recombinate is indicated in the treatment and prophylaxis of bleeding in patients with haemophilia A (congenital factor VIII deficiency). Recombinate is also indicated in the perioperative management of patients with haemophilia A. Recombinate is appropriate for use in children of all ages including the newborn. (Safety and efficacy studies have been performed in both previously treated and previously untreated children). The product in not suitable for the treatment of von Willebrand's disease.

Ngày ủy quyền:

2010-07-01